Vicore Pharma Holding AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,356	3,181	1,982	1,584	1,465	999
Market Cap Growth	73.61%	60.49%	25.12%	8.13%	46.67%	-47.51%
Enterprise Value	2,296	2,345	1,602	1,033	1,295	552
Last Close Price	11.92	11.30	8.45	13.80	17.42	13.54
PS Ratio	951.46	833.44	18.13	-	-	-
PB Ratio	3.39	2.90	1.76	3.48	5.07	2.61
P/TBV Ratio	3.39	2.90	1.76	3.50	6.63	3.16
EV/Sales Ratio	-	614.46	14.65	-	-	-
Debt / Equity Ratio	-	-	-	-	0	0.00
Net Debt / Equity Ratio	-1.07	-1.06	-1.02	-1.06	-0.90	-0.97
Net Debt / EBITDA Ratio	-	2.58	6.15	1.52	0.92	1.28
Net Debt / FCF Ratio	2.60	3.11	7.01	1.93	0.87	1.40
Asset Turnover	0.00	0.00	0.13	-	-	-
Quick Ratio	12.57	9.99	17.90	11.86	5.69	5.67
Current Ratio	12.69	10.28	18.20	12.10	5.81	5.75
Return on Equity (ROE)	-47.19%	-42.92%	-21.28%	-83.53%	-85.79%	-80.37%
Return on Assets (ROA)	-27.61%	-23.53%	-14.05%	-47.99%	-45.54%	-42.76%
Return on Capital Employed (ROCE)	-48.10%	-41.30%	-16.80%	-70.20%	-98.60%	-76.10%
Earnings Yield	-14.14%	-15.01%	-8.51%	-19.63%	-19.69%	-29.68%
FCF Yield	-	-11.81%	-8.32%	-15.75%	-20.47%	-26.55%
Buyback Yield / Dilution	-50.54%	-75.30%	-41.72%	-33.71%	-3.64%	-28.44%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.